BMJ

The impact of obesity on the development and progression of rheumatoid arthritis

Correspondence to Dr A Finckh, Division of Rheumatology, University Hospital of Geneva, Av. Beau-Séjour 26, Geneva 14 CH 1211, Switzerland; axel.finckh{at}hcuge.ch Obesity is a growing global health ...
BMJ

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

Correspondence to Dr John H Stone, Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA 02114, USA; jhstone{at}mgh.harvard.edu IgG4-related disease (IgG4-RD) can cause ...
BMJ

Epidemiology of whiplash: an international dilemma

562 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada TG6 2S2 Whiplash associated disorders have become an international medicolegal and social dilemma. Physicians are ...
BMJ

Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III ...

Objective To evaluate ustekinumab efficacy and safety in psoriatic arthritis (PsA) patients with peripheral arthritis and physician-reported spondylitis (termed the ‘spondylitis subset’). Methods ...
BMJ

Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review

Academic Rheumatology, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK Correspondence to: Dr Edward Roddy Academic Rheumatology, Clinical Sciences Building, Nottingham City ...
BMJ

Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1β and tumour necrosis factor α

Objective: To determine whether IL18 has any indirect effects on osteoclastogenesis mediated by T cells in RA synovium, and compare its effects with those of IL1β and TNFα. Methods: Resting T cells ...
BMJ

Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study

Dr K R Muir, Division of Public Health Medicine and Epidemiology, School of Community Health Sciences, University Hospital, Queen’s Medical Centre, Nottingham, NG7 2UH. OBJECTIVE To investigate the ...
BMJ

Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis

Objectives We developed a patient-reported outcome (PRO) instrument to assess the skin-related quality of life in patients with systemic sclerosis (SSc). Methods Participants with SSc provided input ...
BMJ

Table of contents

F8: Back to the future: how to mix the old and new treatments for SLE, Sjögren's and APS ...
BMJ

SAT0140 Risk of venous thromboembolism in rheumatoid arthritis patients treated with biologic and non-biologic dmards

Background: Individuals with rheumatoid arthritis (RA) have an increased risk of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), compared with non-RA ...
BMJ

Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo ...

Objectives Rheumatoid arthritis (RA) has a considerable disease burden with life-long physical limitations, reduced work productivity and high societal costs. Trials on arthralgia at-risk for RA are ...
BMJ

The type I IFN signature as a biomarker of preclinical rheumatoid arthritis

4 Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands Correspondence to Dr Cornelis L Verweij, Department of Pathology and Rheumatology, VU University Medical Center, ...